Enterobacter

Background

Antibiotic Sensitivities[1]

Enterobacter sp, AmpC neg Enterobacter sp, AmpC pos
R R
R R
R R
R R
R R
R R
R R
R R
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
S S
R R
I R
R R
I R
S R
S R
S R
S R
S R
S R
R R
R R
R R
R R
R R
R R
I R
R R
S S
S S
S S
R R
R R
R R
R R
R R
R R
R R
R R
S S
R R
R R
R R
R R
R R
I I
X1 X1
I I
S S
R R
R R
R R
R R
S S

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

Table Overview

See Also

References

  1. Sanford Guide to Antimicrobial Therapy 2014

Authors:

Ross Donaldson